Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Ji

Showing results (381-390 of 386) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 386 results.
Nature Medicine|May 22, 2024
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trialXiangyu Gao, Ke Ji, Yongning Jia, et al.
Chinese Journal of Integrative Medicine|February 14, 2018
Effect of Kuanxiong Aerosol () on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled TrialQiao-Ning Yang, Rui-Na Bai, Guo-Ju Dong, et al.
Journal of the National Cancer Institute|January 27, 2017
Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node MetastasesXin Gao, Liao-Yuan Li, Jörg Rassler, et al.
Science Advances|March 6, 2020
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapyZiyu Li, Xiangyu Gao, Xinxin Peng, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|August 13, 2013
Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter StudyShao-Li Wang, Cheng-Long Wang, Pei-Li Wang, et al.
The Lancet. Oncology|October 5, 2023
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trialXiangyu Gao, Nong Xu, Ziyu Li, et al.
Pageof 39

Showing results (381-390 of 386) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 386 results.
Nature Medicine|May 22, 2024
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trialXiangyu Gao, Ke Ji, Yongning Jia, et al.
Chinese Journal of Integrative Medicine|February 14, 2018
Effect of Kuanxiong Aerosol () on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled TrialQiao-Ning Yang, Rui-Na Bai, Guo-Ju Dong, et al.
Journal of the National Cancer Institute|January 27, 2017
Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node MetastasesXin Gao, Liao-Yuan Li, Jörg Rassler, et al.
Science Advances|March 6, 2020
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapyZiyu Li, Xiangyu Gao, Xinxin Peng, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|August 13, 2013
Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter StudyShao-Li Wang, Cheng-Long Wang, Pei-Li Wang, et al.
The Lancet. Oncology|October 5, 2023
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trialXiangyu Gao, Nong Xu, Ziyu Li, et al.
Pageof 39